Get the Stockscreener App
1.77
9.94%
0.16
After Hours:
1.65
-0.12
-6.78%
Cardio Diagnostics Holdings Inc stock is traded at $1.77, with a volume of 69,119.
It is up +9.94% in the last 24 hours and down -2.75% over the past month.
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.
See More
Previous Close:
$1.61
Open:
$1.71
24h Volume:
69,119
Relative Volume:
0.03
Market Cap:
$5.24M
Revenue:
$14,800
Net Income/Loss:
$-6.50M
P/E Ratio:
-0.4764
EPS:
-3.7153
Net Cash Flow:
$-6.15M
1W Performance:
+29.20%
1M Performance:
-2.75%
6M Performance:
-39.80%
1Y Performance:
-55.19%
1-Day Range:
$1.63
$1.81
1-Week Range:
$1.38
$1.81
52-Week Range:
$0.97
$7.91
Cardio Diagnostics Holdings Inc Stock (CDIO) Company Profile
Name
Cardio Diagnostics Holdings Inc
Sector
Industry
Phone
855-226-9991
Address
311 W. SUPERIOR STREET, CHICAGO
Compare CDIO vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDIO
Cardio Diagnostics Holdings Inc
|
1.77 | 4.76M | 14,800 | -6.50M | -6.15M | -3.7153 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cardio Diagnostics Holdings Inc Stock (CDIO) Latest News
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Cardio Diagnostics Holdings (CDIO) Surges 6.62% as Shares Test Resistance Near $1.69Professional Trade Ideas - Newser
CDIO Q1 2025 Earnings: Narrower-than-expected loss surprises marketDebt Analysis Report - Newser
Cardio Diagnostics Hldgs Analyst Ratings and Price Targets | NASDAQ:CDIO - Benzinga
CDIO Should I Buy - Intellectia AI
What's Driving Cardio Diagnostics Holdings' Recent Stock Surge - Kavout
Cardio Diagnostics CEO Discusses Growth Strategy and India Expansion on BioMedWire Podcast - citybuzz -
Cardio Diagnostics Holdings (CDIO) CEO Highlights Growth Strategy, India Expansion on BioMedWire Podcast - Yahoo Finance
IBN Announces Latest Episode of The BioMedWire Podcast - GlobeNewswire
Cardio Diagnostics Holdings (CDIO) Focused on Vision for Personalized Heart Care - Yahoo! Finance Canada
Cardio Diagnostics Holdings (CDIO) Offers Broad Suite of AI-Powered Solutions for Cardiovascular Disease Prevention - Yahoo Finance
Cardio Diagnostics Holdings (NASDAQ: CDIO) Focused on Vision for Personalized Heart Care - TradingView
Cardio Diagnostics Aims to Transform Heart Care with AI-Driven Personalized Medicine - citybuzz -
Cardio Diagnostics Holdings (NASDAQ: CDIO) Offers Broad Suite of AI-Powered Solutions for Cardiovascular Disease Prevention - TradingView
Cardio Diagnostics Leverages AI to Address Preventable Cardiovascular Disease - citybuzz -
Cardio Diagnostics Holdings, Inc. 1Q 2026: Revenue $2.68K, EPS ($0.63) — 10-Q Summary - TradingView
Cardio Diagnostics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Cardio Diagnostics (NASDAQ: CDIO) posts Q1 2026 loss, boosts cash via stock sales - Stock Titan
Cardio Diagnostics Poised at Intersection of Precision Medicine and Preventive Care as Cardiovascular Disease Burden Grows - citybuzz -
TradingKey - TradingKey
Number of shareholders of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIO - TradingView
The real value proposition of Cardio Diagn (CDIO) stock (-1.64%) 2026-05-11Earnings Season - newser.com
CDIO Price Today: Cardio Diagnostics Holdings Inc. Stock Price, Quote & Chart | MEXC - MEXC
What XXxs fundamentals reveal about its future (Investors Pile In) 2026-05-08Aggressive Growth Stocks - newser.com
Cardio Diagnostics Holdings (NASDAQ: CDIO) Targets Earlier, More Precise Cardiac Insights - The Globe and Mail
BioMedNewsBreaks — AI Meets Multi-Omics: Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Targets Earlier, More Precise Cardiac Insights - Scott Coop
CDIO Stock Price, Quote & Chart | CARDIO DIAGNOSTICS HOLDINGS (NASDAQ:CDIO) - ChartMill
Cardio Diagnostics Holdings (NASDAQ: CDIO) Advancing Early Detection, Tackling Heart Disease Through AI and Biomarker Insights - TipRanks
Cardio Diagnostics Holdings (CDIO) Advancing Early Detection, Tackling Heart Disease Through AI and Biomarker Insights - Yahoo Finance
Cardio Diagnostics Leverages AI and Biomarkers to Combat Cardiovascular Disease - citybuzz -
CDIOW (Cardio Diag) will share full quarterly earnings details and strategic priorities in its upcoming investor briefing.Consensus Forecast - newser.com
Cardio Diagnostics Holdings (NASDAQ: CDIO) Advancing AI Solutions for Cardiovascular Disease Detection and Management - The Globe and Mail
Cardio Diagnostics Holdings (CDIO) Advancing AI Solutions for Cardiovascular Disease Detection and Management - Yahoo Finance
Why Cardio Diagnostics Holdings (CDIO) is 'One to Watch' - NewMediaWire
Why Cardio Diagnostics Holdings (NASDAQ: CDIO) Is ‘One to Watch’ - TipRanks
Cardio Diagnostics Leverages AI and Epigenetics for Precision Cardiovascular Medicine - citybuzz -
Aug Closing: Is Cardio Diagnostics Holdings Inc Equity Warrant part of any ETFSwing Trade & Verified Short-Term Plans - baoquankhu1.vn
Net current asset value per share of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIOW - TradingView
Is Cardio Diagn (CDIO) Stock Ready to Drop | Price at $1.78, Down 1.38%Social Trading Insights - Newser
Cardio Diagnostics Engages IBN to Enhance Communications Strategy for AI-Powered Cardiovascular Tests - citybuzz -
Cardio Diagnostics Holdings (NASDAQ: CDIO) Engages IBN to Support Corporate Communications Strategy - The Globe and Mail
Aug Rallies: How does Cardio Diagnostics Holdings Inc perform in inflationary periodsWeekly Trade Report & Intraday High Probability Alerts - baoquankhu1.vn
IBN Initiates Coverage of Cardio Diagnostics Holdings Inc. - The Manila Times
Pullback Watch: How does Cardio Diagnostics Holdings Inc score in quality rankingsPrice Action & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Cardio Diagnostics Holdings Inc Stock (CDIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):